EORTC Elderly Task Force and Lung Cancer Group and International Society for Geriatric Oncology (SIOG) experts’ opinion for the treatment of non-small-cell lung cancer in an elderly population
- 28 August 2009
- journal article
- review article
- Published by Elsevier in Annals of Oncology
- Vol. 21 (4) , 692-706
- https://doi.org/10.1093/annonc/mdp360
Abstract
Non-small-cell lung cancer (NSCLC) represents a common health issue in the elderly population. Nevertheless, the paucity of large, well-conducted prospective trials makes it difficult to provide evidence-based clinical recommendations for these patients. The present paper reviews the currently available evidence regarding treatment of all stages of NSCLC in elderly patients. Surgery remains the standard for early-stage disease, though pneumonectomy is associated with higher incidence of postoperative mortality in elderly patients. Given the lack of demonstrated benefit for the use of adjuvant radiotherapy, it is also not recommended in elderly patients. Elderly patients seem to derive the same benefit from adjuvant chemotherapy as younger patients do, with no significant increase in toxicity. For locally advanced NSCLC, concurrent chemoradiotherapy may be offered to selected elderly patients as there is a higher risk for toxicity reported in the elderly population. Third-generation single-agent treatment is considered the standard of care for patients with advanced/metastatic disease. Platinum-based combination chemotherapy needs to be evaluated in prospective trials. Unfortunately, with the exception of advanced/metastatic NSCLC, prospective elderly-specific NSCLC trials are lacking and the majority of recommendations made are based on retrospective data, which might suffer from selection bias. Prospective elderly-specific trials are needed.Keywords
This publication has 106 references indexed in Scilit:
- Comprehensive Geriatric assessment and its clinical impact in oncologyEuropean Journal Of Cancer, 2007
- Comorbidity in older surgical cancer patients: Influence on patient care and outcomeEuropean Journal Of Cancer, 2007
- Surgery of non-small cell lung cancer in the elderlyCurrent Opinion in Oncology, 2007
- Outcome of Surgery for Lung Cancer in Young and Elderly PatientsSurgery Today, 2005
- Surgical Treatment for Lung Cancer in OctogenariansSurgery Today, 2005
- Erlotinib in Previously Treated Non–Small-Cell Lung CancerNew England Journal of Medicine, 2005
- Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to GefitinibNew England Journal of Medicine, 2004
- Global cancer statistics in the year 2000The Lancet Oncology, 2001
- Geriatric oncologyEuropean Journal Of Cancer, 2000
- Lung cancer in the elderlyEuropean Journal Of Cancer, 1997